TSPAN10
geneOn this page
Also known as OCSP
Summary
TSPAN10 (tetraspanin 10, HGNC:29942) is a protein-coding gene on chromosome 17q25.3, encoding Tetraspanin-10 (Q9H1Z9). Part of TspanC8 subgroup, composed of 6 members that interact with the transmembrane metalloprotease ADAM10.
Enables enzyme binding activity. Involved in establishment of protein localization to organelle. Predicted to be located in membrane. Predicted to be active in plasma membrane.
Source: NCBI Gene 83882 — RefSeq curated summary.
At a glance
- GWAS associations: 13
- Clinical variants (ClinVar): 53 total
- MANE Select transcript:
NM_001290212
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29942 |
| Approved symbol | TSPAN10 |
| Name | tetraspanin 10 |
| Location | 17q25.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OCSP |
| Ensembl gene | ENSG00000182612 |
| Ensembl biotype | protein_coding |
| Entrez | 83882 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 6 protein_coding, 1 retained_intron, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000571707, ENST00000571914, ENST00000611590, ENST00000621293, ENST00000696047, ENST00000696048, ENST00000869738, ENST00000869739, ENST00000869740
RefSeq mRNA: 2 — MANE Select: NM_001290212
NM_001290212, NM_031945
CCDS: CCDS58608
Canonical transcript exons
ENST00000611590 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003653175 | 81644992 | 81645629 |
| ENSE00003714871 | 81647901 | 81648749 |
| ENSE00003749738 | 81642307 | 81642448 |
| ENSE00003965890 | 81637196 | 81637406 |
Expression profiles
Bgee: expression breadth ubiquitous, 160 present calls, max score 98.95.
FANTOM5 (CAGE): breadth broad, TPM avg 6.1663 / max 410.9174, expressed in 571 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 163345 | 3.2422 | 370 |
| 163344 | 2.9241 | 468 |
Top tissues by expression
236 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pigmented layer of retina | UBERON:0001782 | 98.95 | gold quality |
| kidney epithelium | UBERON:0004819 | 94.48 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 91.55 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 91.50 | gold quality |
| myocardium | UBERON:0002349 | 88.09 | gold quality |
| upper arm skin | UBERON:0004263 | 87.65 | gold quality |
| vena cava | UBERON:0004087 | 86.35 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 85.93 | gold quality |
| gingival epithelium | UBERON:0001949 | 82.42 | silver quality |
| gingiva | UBERON:0001828 | 81.90 | silver quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 81.90 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.78 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 79.28 | gold quality |
| vastus lateralis | UBERON:0001379 | 78.67 | gold quality |
| pericardium | UBERON:0002407 | 77.87 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 77.83 | gold quality |
| quadriceps femoris | UBERON:0001377 | 77.46 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 77.28 | gold quality |
| cardia of stomach | UBERON:0001162 | 77.08 | gold quality |
| saphenous vein | UBERON:0007318 | 77.01 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 76.82 | gold quality |
| pons | UBERON:0000988 | 76.78 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 76.75 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 76.71 | gold quality |
| buccal mucosa cell | CL:0002336 | 76.61 | silver quality |
| trachea | UBERON:0003126 | 76.22 | gold quality |
| nipple | UBERON:0002030 | 76.21 | silver quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 76.16 | gold quality |
| pylorus | UBERON:0001166 | 76.08 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 76.07 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-135 | yes | 1199.42 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
11 targeting TSPAN10, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6851-5P | 100.00 | 65.63 | 1294 |
| HSA-MIR-1275 | 99.47 | 67.90 | 2749 |
| HSA-MIR-3960 | 99.41 | 66.11 | 96 |
| HSA-MIR-4651 | 99.06 | 67.57 | 2002 |
| HSA-MIR-608 | 98.93 | 67.83 | 2013 |
| HSA-MIR-6846-5P | 98.81 | 65.86 | 1121 |
| HSA-MIR-6848-5P | 98.81 | 65.49 | 1126 |
| HSA-MIR-8072 | 98.27 | 66.24 | 83 |
| HSA-MIR-10400-5P | 96.91 | 66.00 | 56 |
| HSA-MIR-4467 | 96.51 | 64.44 | 69 |
| HSA-MIR-10392-3P | 88.79 | 61.83 | 122 |
Literature-anchored findings (GeneRIF, showing 1)
- Genetic variant within the TSPAN10 gene is associated with strabismus. (PMID:31073882)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tspan10 | ENSDARG00000044767 |
| mus_musculus | Tspan10 | ENSMUSG00000039691 |
| rattus_norvegicus | Tspan10 | ENSRNOG00000046076 |
Paralogs (32): TSPAN6 (ENSG00000000003), CD9 (ENSG00000010278), TSPAN9 (ENSG00000011105), TSPAN17 (ENSG00000048140), TSPAN32 (ENSG00000064201), CD82 (ENSG00000085117), TSPAN15 (ENSG00000099282), CD37 (ENSG00000104894), UPK1A (ENSG00000105668), TSPAN12 (ENSG00000106025), TSPAN13 (ENSG00000106537), TSPAN14 (ENSG00000108219), CD81 (ENSG00000110651), TSPAN11 (ENSG00000110900), PRPH2 (ENSG00000112619), UPK1B (ENSG00000114638), TSPAN1 (ENSG00000117472), TSPAN8 (ENSG00000127324), TSPAN16 (ENSG00000130167), TSPAN2 (ENSG00000134198), CD63 (ENSG00000135404), TSPAN31 (ENSG00000135452), TSPAN3 (ENSG00000140391), CD53 (ENSG00000143119), ROM1 (ENSG00000149489), TSPAN7 (ENSG00000156298), TSPAN18 (ENSG00000157570), TSPAN33 (ENSG00000158457), TSPAN5 (ENSG00000168785), CD151 (ENSG00000177697), TSPAN4 (ENSG00000214063), TSPAN19 (ENSG00000231738)
Protein
Protein identifiers
Tetraspanin-10 — Q9H1Z9 (reviewed: Q9H1Z9)
Alternative names: Oculospanin
All UniProt accessions (2): A0A087X235, Q6PJ65
UniProt curated annotations — full annotation on UniProt →
Function. Part of TspanC8 subgroup, composed of 6 members that interact with the transmembrane metalloprotease ADAM10. This interaction is required for ADAM10 exit from the endoplasmic reticulum and for enzymatic maturation and trafficking to the cell surface as well as substrate specificity. Different TspanC8/ADAM10 complexes have distinct substrates.
Subunit / interactions. Interacts with ADAM10.
Subcellular location. Cell membrane.
Tissue specificity. Expressed in the eye, including iris, ciliary body, retinal pigment epithelium, but not lens (protein level).
Similarity. Belongs to the tetraspanin (TM4SF) family.
RefSeq proteins (2): NP_001277141, NP_114151 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008952 | Tetraspanin_EC2_sf | Homologous_superfamily |
| IPR018499 | Tetraspanin/Peripherin | Family |
| IPR018503 | Tetraspanin_CS | Conserved_site |
Pfam: PF00335
UniProt features (25 total): topological domain 5, sequence conflict 5, disulfide bond 4, transmembrane region 4, region of interest 2, sequence variant 2, chain 1, compositionally biased region 1, glycosylation site 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9HV7 | X-RAY DIFFRACTION | 1.55 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H1Z9-F1 | 77.71 | 0.58 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (4): 212–279, 213–243, 229–237, 244–258
Glycosylation sites (1): 228
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 39 (showing top):
GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON, CEBPZ_TARGET_GENES, CIITA_TARGET_GENES, GLI4_TARGET_GENES, KAT2A_TARGET_GENES, ZFP3_TARGET_GENES, ZNF146_TARGET_GENES, ZNF7_TARGET_GENES, ZNF711_TARGET_GENES, ZNF85_TARGET_GENES, ZSCAN30_TARGET_GENES, GSE17721_CTRL_VS_POLYIC_8H_BMDC_DN, HU_FETAL_RETINA_RPE, DESCARTES_MAIN_FETAL_RETINAL_PIGMENT_CELLS
GO Biological Process (1): establishment of protein localization to organelle (GO:0072594)
GO Molecular Function (1): enzyme binding (GO:0019899)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| establishment of protein localization | 1 |
| protein binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
756 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TSPAN10 | NPLOC4 | Q8TAT6 | 699 |
| TSPAN10 | RAD51B | O15315 | 524 |
| TSPAN10 | LRIT1 | Q9P2V4 | 494 |
| TSPAN10 | FIZ1 | Q96SL8 | 482 |
| TSPAN10 | CD81 | P18582 | 474 |
| TSPAN10 | CD9 | P21926 | 473 |
| TSPAN10 | RD3L | P0DJH9 | 467 |
| TSPAN10 | TSPAN14 | Q8NG11 | 434 |
| TSPAN10 | B3GLCT | Q6Y288 | 431 |
| TSPAN10 | PILRB | Q9UKJ0 | 431 |
| TSPAN10 | ADAM10 | O14672 | 425 |
| TSPAN10 | ARMS2 | P0C7Q2 | 419 |
| TSPAN10 | TSPAN32 | Q96QS1 | 413 |
| TSPAN10 | TSPAN9 | O75954 | 408 |
| TSPAN10 | TSPAN12 | O95859 | 408 |
IntAct
16 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HSD17B13 | TSPAN10 | psi-mi:“MI:0915”(physical association) | 0.590 |
| ADGRG5 | KLRG2 | psi-mi:“MI:0914”(association) | 0.530 |
| ADAM10 | TSPAN10 | psi-mi:“MI:0915”(physical association) | 0.400 |
| LHFPL1 | TSPAN10 | psi-mi:“MI:0915”(physical association) | 0.400 |
| PNLDC1 | C1QL1 | psi-mi:“MI:0914”(association) | 0.350 |
| TSPAN10 | KLRG2 | psi-mi:“MI:0914”(association) | 0.350 |
| OR6T1 | PSMD11 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC26A6 | SLC25A17 | psi-mi:“MI:0914”(association) | 0.350 |
| OR52B2 | PCCA | psi-mi:“MI:0914”(association) | 0.350 |
| PTX3 | OFD1 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC12A9 | PGRMC1 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC44A1 | UPK3BL1 | psi-mi:“MI:0914”(association) | 0.350 |
| TP53 | PPM1G | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (77): ADAM10 (Affinity Capture-Western), TSPAN10 (Affinity Capture-MS), TSPAN10 (Affinity Capture-MS), TSPAN10 (Affinity Capture-MS), TSPAN10 (Affinity Capture-MS), TSPAN10 (Affinity Capture-RNA), TSPAN10 (Affinity Capture-MS), TSPAN10 (Affinity Capture-MS), TSPAN10 (Affinity Capture-MS), TSPAN10 (Affinity Capture-MS), TSPAN10 (Affinity Capture-MS), TSPAN10 (Proximity Label-MS), TSPAN10 (Affinity Capture-MS), FITM2 (Affinity Capture-MS), FAM134C (Affinity Capture-MS)
ESM2 similar proteins: A6NGC4, A6NKX4, A6NM10, F1NZP5, O96011, P0C242, P27544, P27545, Q0VCY6, Q2TBI8, Q3SYU3, Q4V8E5, Q5F2F2, Q5JZQ7, Q5RFI0, Q5U2T1, Q5U419, Q6AYM9, Q6GQT6, Q6PIS1, Q6TCG5, Q6UXD7, Q6UXT9, Q71RH2, Q7TNV1, Q7Z403, Q80ZE4, Q863Y8, Q86WI3, Q8BMT9, Q8CHK3, Q8IU68, Q8IXF9, Q8N9H8, Q8TBR7, Q8VC26, Q8WUG5, Q96N66, Q99640, Q99JT6
Diamond homologs: A0A8M2B5N2, A0A8V0ZLT4, A1L157, B5X3I6, O43657, O60635, O60636, O70352, O95859, O97703, P19075, P19397, P21926, P24485, P27701, P28648, P30409, P30932, P31053, P35762, P40237, P40239, P40240, P40241, P41731, P60033, P60034, P61170, P61171, P62079, P62080, Q17QJ5, Q29RH7, Q2KHY8, Q2KIS9, Q3SYV5, Q3T0S3, Q3ZBH3, Q3ZCD0, Q4R7W6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
53 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 44 |
| Likely benign | 4 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
658 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:81637301:G:GT | donor_gain | 0.9900 |
| 17:81637403:ACAGG:A | donor_loss | 0.9900 |
| 17:81637407:G:GA | donor_loss | 0.9900 |
| 17:81637407:G:GG | donor_gain | 0.9900 |
| 17:81645627:CCT:C | donor_gain | 0.9900 |
| 17:81645630:G:GG | donor_gain | 0.9900 |
| 17:81637404:CAG:C | donor_gain | 0.9800 |
| 17:81645182:TC:T | donor_gain | 0.9800 |
| 17:81645625:AACCT:A | donor_gain | 0.9800 |
| 17:81645626:ACCT:A | donor_gain | 0.9800 |
| 17:81637405:AG:A | donor_gain | 0.9700 |
| 17:81637406:GG:G | donor_gain | 0.9700 |
| 17:81637408:T:G | donor_loss | 0.9700 |
| 17:81645281:G:T | donor_gain | 0.9700 |
| 17:81645626:ACCTG:A | donor_loss | 0.9700 |
| 17:81645627:CCTGT:C | donor_loss | 0.9700 |
| 17:81645628:CT:C | donor_gain | 0.9700 |
| 17:81645628:CTG:C | donor_loss | 0.9700 |
| 17:81645629:TGTGA:T | donor_loss | 0.9700 |
| 17:81645630:GT:G | donor_loss | 0.9700 |
| 17:81645631:T:A | donor_loss | 0.9700 |
| 17:81645632:G:GC | donor_loss | 0.9700 |
| 17:81637288:A:T | donor_gain | 0.9600 |
| 17:81645121:GCCT:G | donor_gain | 0.9600 |
| 17:81645281:G:GT | donor_gain | 0.9600 |
| 17:81645613:G:GT | donor_gain | 0.9600 |
| 17:81645633:A:AT | donor_loss | 0.9600 |
| 17:81645634:G:C | donor_loss | 0.9600 |
| 17:81647896:TGCA:T | acceptor_loss | 0.9600 |
| 17:81647897:GCA:G | acceptor_loss | 0.9600 |
AlphaMissense
2235 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000126252 (17:81645382 C>T), RS1000202766 (17:81637097 G>A), RS1000327775 (17:81645694 C>T), RS1000803042 (17:81637984 T>C), RS1000867415 (17:81639185 G>A), RS1000915233 (17:81636480 T>C), RS1000944261 (17:81644229 C>G,T), RS1001079004 (17:81640867 T>C), RS1001173218 (17:81638251 A>G), RS1001430225 (17:81641110 A>T), RS1001671386 (17:81640252 G>A), RS1001782775 (17:81635212 G>A), RS1001981653 (17:81635404 G>A), RS1002450586 (17:81644668 G>A), RS1002575476 (17:81644878 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
13 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003219_14 | Advanced age-related macular degeneration | 2.000000e-11 |
| GCST003997_35 | Myopia | 2.000000e-18 |
| GCST005580_29 | Intraocular pressure | 2.000000e-13 |
| GCST006291_89 | Spherical equivalent or myopia (age of diagnosis) | 3.000000e-09 |
| GCST006976_1 | Macular thickness | 1.000000e-118 |
| GCST006986_12 | Red vs. brown/black hair color | 3.000000e-21 |
| GCST006989_54 | Brown vs. black hair color | 8.000000e-70 |
| GCST007157_9 | Corneal astigmatism | 8.000000e-09 |
| GCST007159_31 | Corneal astigmatism | 2.000000e-13 |
| GCST007486_24 | Hair morphology traits | 2.000000e-09 |
| GCST007486_4 | Hair morphology traits | 1.000000e-08 |
| GCST009474_2 | Central retinal vein equivalent | 4.000000e-09 |
| GCST010002_133 | Refractive error | 2.000000e-50 |
EFO canonical traits (6, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:1001492 | atrophic macular degeneration |
| EFO:0004695 | intraocular pressure measurement |
| EFO:0004847 | age at onset |
| EFO:0003924 | hair color |
| EFO:1002040 | Corneal astigmatism |
| EFO:0010554 | retinal vasculature measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cisplatin | affects cotreatment, increases expression | 2 |
| Valproic Acid | affects cotreatment, increases expression, increases methylation | 2 |
| Particulate Matter | decreases expression, increases expression | 2 |
| afuresertib | increases expression | 1 |
| FR900359 | affects phosphorylation | 1 |
| propionaldehyde | increases expression | 1 |
| sodium arsenate | decreases expression, increases abundance | 1 |
| o,p’-DDT | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| ferrous chloride | decreases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| AM 251 | increases expression | 1 |
| nutlin 3 | affects cotreatment, increases expression | 1 |
| jinfukang | increases expression, affects cotreatment | 1 |
| Arsenic | increases abundance, decreases expression | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Dactinomycin | affects cotreatment, increases expression | 1 |
| Estradiol | decreases expression | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Mustard Gas | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Zearalenone | decreases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| beta-Naphthoflavone | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): wet macular degeneration